Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real‐Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy
Bimekizumab demonstrated significant, rapid improvements in real-world PsA patients, including those with prior biologic failures. Its favorable safety profile and effectiveness highlight its potential as a valuable treatment option for PsA.
Authors
- Diego Orsini (ORCID: https://orcid.org/0000-0002-3190-3988)
- Annunziata Dattola (ORCID: https://orcid.org/0000-0001-9504-5882)
- Andrea Picchianti Diamanti (ORCID: https://orcid.org/0000-0002-8552-4641)
- Antonio Giovanni Richetta (ORCID: https://orcid.org/0000-0002-7170-3972)
- Nicoletta Bernardini (ORCID: https://orcid.org/0000-0002-6295-3574)
- Gaia Moretta (ORCID: https://orcid.org/0000-0002-8839-5961)
- Giacomo Caldarola (ORCID: https://orcid.org/0000-0002-8837-9232)
- Alessandro Giunta (ORCID: https://orcid.org/0000-0003-3589-9346)
- Gianluca Pagnanelli (ORCID: https://orcid.org/0000-0003-0961-6779)
- Elena Campione (ORCID: https://orcid.org/0000-0001-7447-6798)
- Domenico Giordano (ORCID: https://orcid.org/0000-0003-0624-2097)
- Eleonora De Luca (ORCID: https://orcid.org/0000-0003-3893-2869)
- Veronica Blundo
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Rome Tor Vergata (IT)
- Agostino Gemelli University Polyclinic (IT)
- Istituto Dermopatico dell'Immacolata (IT)
- Policlinico Tor Vergata (IT)
- San Gallicano Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1111/ijd.17927
- Citations
- 1
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.67